CUMEC
LIVE

Serial Number

79310735

Owner

Noster Inc.

Attorney

Kumiko Ide

Filing Date

Feb 8, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CUMEC Trademark

Serial Number: 79310735 • Registration: 6841339

CUMEC is a trademark filed by Noster Inc. on February 8, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Noster Inc. (26 trademarks)

35-3, Minamibiraki,

Entity Type: 99

Trademark Details

Filing Date

February 8, 2021

Registration Date

September 13, 2022

Published for Opposition

June 28, 2022

Goods & Services

Educational services, namely, conducting workshops and seminars in the field of arts, crafts, sports, and general health knowledge; educational services, namely, providing a website in the field of sports and arts and crafts; instruction services in the field of arts, crafts, sports, and general health knowledge; arranging, conducting and organization of seminars in the field of arts, crafts, sports, and general health knowledge

Pharmaceutical preparations for the treatment and prevention of diabetes, diabetic complication, hyperlipidemia, hyperuricemia, gout, lifestyle related metabolic and endocrine diseases, nutritional disorders, impaired glucose tolerance, metabolic syndrome, obesity and lipid disorder, hypertension, hyperglycemia, ischemic heart disease, hyperinsulinemia, arteriosclerosis, myocardial infarction, angina pectoris, aneurysm, chronic kidney disease, renal calculi, kidney disease, pyelonephritis, nephritis, urethritis, cystitis, hypercholesterolemia and high triglyceridemia, bronchitis, pulmonary emphysema and lung inflammation, abnormality of the intestinal flora, abdominal distension, peptic ulcer, intestinal disease, inflammatory disorder, irritable bowel syndrome, gastric ulcer, inflammatory bowel disease, Crohn's disease, diverticulitis, liver cirrhosis, fatty liver, diarrhea, constipation, loose stool disease, hepatic inflammation, non-alcoholic steatohepatitis, viral hepatitis, alcoholic hepatitis, dental disease, periodontal diseases, stomatitis, xerostomia and cyst, immune related diseases and abnormalities, type I, II, III, IV and V allergy, pollinosis, atopic dermatitis, psoriasis, autoimmune disease and connective tissue disease, rheumatism, osteoporosis and articular inflammation, pathogenic microbial and malignant neoplastic infections, cancer and malignant tumor, mental disorder, dementia, Alzheimer's disease, bipolar disorder, depression, anorexia, insomnia, cerebral apoplexy, cerebral infarction, autism, neuroinflammation, overwork related disease and nerve inflammation related diseases and cancers resulting from chronic inflammation, ophthalmic disease, ocular inflammation, otorhinolaryngology disease and skin inflammation; reagent paper for medical purposes; fumigants for agricultural purposes; fungicides for agricultural purposes; rodenticides for agricultural purposes; insecticides for agricultural purposes; herbicides being weedkillers; insect-repellents for agricultural purposes; antiseptics for agricultural purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages for skin wounds; breast-nursing pads; cotton swabs for medical use; dental materials, namely, dental porcelain materials, materials for making dental impressions and composite materials for dental and dental technical purposes; diapers, namely, adult diapers and baby diapers; infant diaper covers; fly catching paper; mothproofing paper; lacteal flour for babies; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages for babies adapted for medical use; food for babies; dietary supplements for animals; semen for artificial insemination

Paper and cardboard; printed matter, namely, manuals, newspapers, photographs, magazines, newsletters, posters, calendars and books all in the field of health

Advertising and publicity services; retail store services and wholesale store services featuring processed food

Providing medical information; physical examination

Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 9, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 15, 2022 FICS
FINAL DISPOSITION PROCESSED
Dec 15, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 13, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 13, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 13, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 28, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2022 NONP
ASSIGNED TO LIE
May 20, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 19, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 19, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 19, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 19, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 19, 2022 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 4, 2022 GNFN
FINAL REFUSAL E-MAILED
Apr 4, 2022 GNFR
FINAL REFUSAL WRITTEN
Apr 4, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2022 TROA
REFUSAL PROCESSED BY IB
Oct 4, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 16, 2021 RFCS
REFUSAL PROCESSED BY MPU
Sep 16, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 3, 2021 RFCR
NON-FINAL ACTION WRITTEN
Sep 2, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 1, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
May 21, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 17, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 13, 2021 REPR